ALZN
Alzamend Neuro, Inc.
Latest Form 4:Purchase$109KbyAULT MILTON C III (Director) · filed Apr 16, 2026
Alzamend Neuro, Inc. (ALZN) has 8 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Apr 16, 2026.
The most active filer is Director AULT MILTON C III with 12 filings.
- Industry:Biotechnology
- CEO:Stephan Jackman
- Employees:7
- HQ:Atlanta, GA, US
- IPO:2021-06-15
Insider Buying
$109K
reported purchases (SEC code P)
Insider Selling
$1.1M
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Purchase | 108,388 | $109K | Apr 16 | SEC ↗ | |
| Director | Sale | 1,851 | $4K | Dec 30 | SEC ↗ | |
Horne William B.First filing | Director | Sale | 3,333 | $7K | Dec 23 | SEC ↗ |
McGrath Lynne FaheyFirst filing | Director | Sale | 30 | $69 | Oct 24 | SEC ↗ |
| Director | Sale | 101,394 | $247K | Oct 10 | SEC ↗ | |
| Director | Sale | 20,397 | $47K | Oct 10 | SEC ↗ | |
| Director | Sale | 82,033 | $201K | Oct 8 | SEC ↗ | |
| Director | Sale | 57,379 | $143K | Oct 8 | SEC ↗ | |
| Director | Sale | 36,777 | $86K | Oct 3 | SEC ↗ | |
| Director | Sale | 20,686 | $50K | Oct 3 | SEC ↗ | |
| Director | Sale | 65,903 | $161K | Oct 3 | SEC ↗ | |
AULT MILTON C IIIFirst filing | Director, 10% Owner | Sale | 37,738 | $87K | Sep 30 | SEC ↗ |
AULT MILTON C IIIFirst filing | Director, 10% Owner | Sale | 38,324 | $88K | Sep 30 | SEC ↗ |
AULT MILTON C IIIFirst filing | Director, 10% Owner | Sale | 3,566 | $8K | Sep 30 | SEC ↗ |
Related companies
Alzamend Neuro, Inc. is in the Healthcare sector.